Heart patients to fight fatigue with smartphone farming game
NCT ID NCT05641662
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This international study tests whether a smartphone game called Heart Farming can help inactive heart failure patients sit less and move more. 750 participants will either get standard activity advice or the game, which rewards walking with virtual farm products. The goal is to see if the game improves exercise capacity, reduces frailty, and boosts quality of life over 3 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Heart Farming mobile exergame
- What this could lead to
- If it works, this could offer a fun, accessible way for heart failure patients to become more active and improve their daily life.
- What could go wrong
- This is a behavioral intervention, not a drug; results depend on patient engagement. The study is early-stage and may not show significant benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 750 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2022
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrREF) or reduced ejection fraction (HFrEF) can be included. 2. Clinically stable 3. Physically inactive 4. Older than 18 years, there is no upper age limit, 5. Speak/understand the language of the country where the study is taking place. 6. Wanting to use a smartphone for the study (if patients do not have a smartphone, they can borrow it from the study team for the duration of the study) Exclusion Criteria: 1. Unable to use an exergame due to visual, hearing, cognitive impairment assessed by HF nurse or cardiologist. 2. Not being able to perform the 6-minute walk test. 3. Not being able or willing to wear an activity monitor. 4. Currently included in a rehabilitation program 5. Lack of willingness to play an exergame. 6. Co-morbidity that hinders benefitting for this form of exercise (history of stroke, severe cognitive dysfunction, or a life expectancy shorter than 6 months).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
10 sites in 4 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Germans Trias i Pujol Hospital
RECRUITINGBarcelona, Spain
-
Hospital de Bellvitge
RECRUITINGBarcelona, Spain
-
Hospital del Mar
ACTIVE_NOT_RECRUITINGBarcelona, Spain
-
INCLIVA
RECRUITINGValencia, Spain
-
Jönköping Hospital Rydhov
RECRUITINGJönköping, Sweden
-
Kalmar Länssjukhuset
TERMINATEDKalmar, Sweden
-
Linköping University Hospital
RECRUITINGLinköping, Sweden
-
P. J. Safarik University
RECRUITINGKošice, Slovakia
-
Primary Health Care Centers Östergötland
RECRUITINGNorrköping, 60591, Sweden
-
Universidade do Porto Faculdade de Medicina
RECRUITINGPorto, Portugal
-
Vrinnevisjukhuset
RECRUITINGNorrköping, Sweden
-
Xarxa Assistencial Universitaria
RECRUITINGManresa, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Two eggs a day put to the test for heart health
- A soft patch that watches your heart beat in real time
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?